New drug aims to slow kidney damage in patients with high uric acid
NCT ID NCT07323095
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new medicine called ABP-671 in 80 adults with chronic kidney disease and high uric acid levels. Participants will receive either the drug or a placebo for 40 weeks. The main goal is to see if the drug reduces protein in the urine, a sign of kidney damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, 100000, China
-
Genesis Research services
Newcastle, New South Wales, 2019, Australia
-
Jiangsu Province Hospital
Nanjing, Jiangsu, 210000, China
-
Paratus Clinical Research Brisbane
Brisbane, Queensland, Australia
-
Peking University First Hospital
Beijing, Beijing Municipality, 100000, China
-
Renal Research Gosford Pty Ltd
Gosford, New South Wales, 2250, Australia
-
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200000, China
-
Sir Run Run Shaw Hospital , affiliated with the Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310000, China
-
Xuanwu Hospital Capital Medical University
Beijing, Beijing Municipality, 100000, China
-
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, 310000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a drug that boosts red blood cells help anemia in kidney disease?
- Predicting kidney trouble in older adults: a data-driven approach to clearer lab results
- Could delaying kidney implant during heart transplant reduce complications?
- Can a new tablet formulation improve how a kidney disease drug is absorbed?
- New drug aims to reduce kidney damage in chronic disease
- Contrast dye Double-Dose: new study tracks kidney fallout in ICU patients